• Specialties
  • Topics
  • Journal
  • Conference
  • Institutional
    • Allergy
    • Anesthesiology
    • Cardiology
    • Cosmetic Surgery
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Practice
    • Gastroenterology
    • Geriatrics
    • Hematology & Oncology
    • HIV & AIDS
    • Infectious Disease
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing
    • OBGYN &Women’s Health
    • Ophthalmology
    • Orthopedics
    • Otolaryngology
    • Pain Management
    • Pathology
    • Pediatrics
    • Pharmacy
    • Psychiatry
    • Pulmonology
    • Radiology
    • Rheumatology
    • Surgery
    • Urology
  • What's Popular

    • Prescription Drugs
    • Heart / Stroke-Related
    • Surgery: Misc.
    • Kids
    • Doctors
    • Infections
    • Diabetes: Misc.
    • Diabetes: Type II
    • Pregnancy
    • Cancer: Misc.
    • All Topics
  • What's Popular

    • Category 1
  • What's Popular

    • Category 1
  • Medical News
  • >
  • Diabetes: Type II

Latest Diabetes: Type II news

Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists

posted April 30th
by modernClinician Editorial Team

Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes

posted April 30th
by modernClinician Editorial Team

GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM

posted April 17th
by modernClinician Editorial Team

Certain Combinations of Food Additives May Increase Risk for Type 2 Diabetes

posted April 16th
by modernClinician Editorial Team

Editor's Recommendations

HHS, FDA Offer Timeline for Phasing Out Petroleum-Based Food Dyes

Tirzepatide Dispensations Increased Rapidly After Approval

Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk

Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM

Related Articles

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors

Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide

Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2

Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors

Monthly Specialist Briefings

  • Three New Color Food Additives From Natural Sources Approved by FDA
  • FDA Warns of Possible Bacteria Contamination of Tattoo Inks
  • Trump Taps Wellness Influencer Casey Means for Surgeon General
  • Guidelines Updated for Nonoccupational Postexposure Prophylaxis for HIV
  • Multicancer Early Detection Screening Improves Patient Outcomes
  • Women Have Higher Risk for COPD Than Men, Regardless of Smoking History
  • No Negative Psychological Impact Seen for Disclosing Aβ Status
  • Computer-Aided Design and Manufacturing Assists Jaw Reconstruction
  • Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting
  • Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults
  • Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial
  • Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24
  • North Dakota Becomes the Latest State to Report Measles Outbreak
  • Targeted Grant Terminations Have Affected 694 NIH Grants
  • Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill
  • Changing Trends Seen in Psychotherapy in Outpatient Mental Health Care
  • Increase in Nicotine Pouch Use Seen Among U.S. High School Students
  • Teens With Mental Health Conditions Spend More Time Daily on Social Media
  • Female Ophthalmology Trainees Perform Fewer Cataract Procedures During Residency
  • Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer
  • Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events
  • Nirsevimab Effective for Reducing Burden of RSV in Infants
  • Mindfulness Training Improved Positive Emotion Regulation in OUD
  • False-Negative Rate High for Seated Saline Suppression Test for Primary Aldosteronism
  • Scalable Symptom Monitoring Intervention May Up Asthma-Related QoL in Subgroup of Adults
  • Study IDs Trends in 2015 to 2023 Mortality for Chronic Liver Disease
  • Europe Launches $565 Million Campaign to Attract U.S. Scientists
  • Dr. Vinay Prasad to Head FDA Vaccine, Biologics Division
  • Top FDA Inspection Official to Retire Amid Staff Frustration
  • Depressive Symptoms Increased for U.S. Adults During Pandemic
  • Ultraprocessed Food Consumption Linked to Nonmotor Prodromal Parkinson Disease
  • American Association for Cancer Research, April 25-30
  • Neuromodulation Methods Show Comparable Outcomes for Neurogenic Bladder in Women With MS
  • Pregnancy Checkbox on Death Certificates Tied to Increase in Reported Rates of Maternal Mortality
  • Kidney Transplant Rate Increasing, but Efficiency of Allocation System Low
  • Real-Time AI-Driven Decision Support Aids Catheter Ablation
  • Nearly Two-Thirds of U.S. Adults Have Experienced In-Person Gun Violence
  • Racial Disparities Persist in Immediate Breast Reconstruction Rates
  • Global Burden of Atopic Dermatitis in Older Adults Is Considerable
  • Quality Improvement Program Aids Antibiotic Duration for Common Infections in Children
  • Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
  • COVID Boosters Might Not Be Updated for Next Season, FDA Commissioner Says
  • Salmonella Outbreak in 6 States Tied to Backyard Poultry, CDC Says
  • $800M in LGBTQ Health Research Funding Nixed by Trump Administration
  • Obtaining Second Opinion Delays Treatment for Breast Cancer, but Not Appreciably
  • 72 Percent of Infants Immunized Against Respiratory Syncytial Virus
  • No Increase Seen in Risk for Incident Diverticulitis With Nuts, Seeds, Corn Intake
  • Higher Stress Tied to Worse Respiratory Outcomes With COPD
  • Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women
  • One in 10 U.S. Internal Medicine Doctors Report High Degree of Burnout

Stay Connected

About
  • About Us
  • Privacy Policy
  • Terms of Use
  • Advertising
Connect - test
  • Facebook
  • Twitter